Shashank Upadhye Quoted in Law360
“Judges Warn Drug IP Attys To Dial Back Legal Maneuvers”

Seyfarth Shaw Intellectual Property partner Shashank Upadhye is quoted in a July 19 Law360 article discussing the recent American Conference Institute’s two-day Legal and Regulatory Summit on Generic Drugs, which he attended. The article notes three takeaways from the conference, including 1) IP attorneys must rein in paperwork and disputes, 2) Lawyers hope the FDA backs down on generic drug labels, and 3) Generics, brands have strong legal strategies in risk evaluation and mitigation strategies  (REMS) fight.